๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Tacrolimus - Medicines in Ireland

26 authorised products containing Tacrolimus, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 26 authorised medicines
MedicineActive substanceLicence holderStatus
Advagraf 0.5 mg prolonged-release hard capsules
EU/1/07/387/001-002
Tacrolimus Astellas Pharma Europe BV โ€”
Advagraf 0.5 mg prolonged-release hard capsules
EU/1/07/387/1-2
Tacrolimus Astellas Pharma Europe BV โ€”
Advagraf 1 mg prolonged-release hard capsules
EU/1/07/387/003-006
Tacrolimus Astellas Pharma Europe BV โ€”
Advagraf 1 mg prolonged-release hard capsules
EU/1/07/387/3-6
Tacrolimus Astellas Pharma Europe BV โ€”
Advagraf 3 mg prolonged-release hard capsules
EU/1/07/387/011-013
Tacrolimus Astellas Pharma Europe BV โ€”
Advagraf 3 mg prolonged-release hard capsules
EU/1/07/387/11-13
Tacrolimus Astellas Pharma Europe BV โ€”
Advagraf 5 mg prolonged-release hard capsules
EU/1/07/387/007-008
Tacrolimus Astellas Pharma Europe BV โ€”
Advagraf 5 mg prolonged-release hard capsules
EU/1/07/387/7-8
Tacrolimus Astellas Pharma Europe BV โ€”
Modigraf 0.2 mg granules for oral suspension
EU/1/09/523/001
Tacrolimus Astellas Pharma Europe BV โ€”
Modigraf 1 mg granules for oral suspension
EU/1/09/523/002
Tacrolimus Astellas Pharma Europe BV โ€”
Prograf 0.5 mg hard capsules
PA1241/014/001
Tacrolimus Astellas Pharma Co. Limited Marketed
Prograf 0.5 mg hard capsules
PPA0465/435/001
Tacrolimus PCO Manufacturing Ltd. โ€”
Prograf 0.5 mg hard capsules
PPA1463/165/001
Tacrolimus IMED Healthcare Ltd., โ€”
Prograf 1 mg hard capsules
PA1241/014/002
Tacrolimus Astellas Pharma Co. Limited Marketed
Prograf 5 mg hard capsules
PA1241/014/003
Tacrolimus Astellas Pharma Co. Limited Marketed
Prograf 5 mg hard capsules
PPA1463/165/002
Tacrolimus IMED Healthcare Ltd., โ€”
Prograf 5 mg/ml concentrate for solution for infusion
PA1241/014/004
Tacrolimus Astellas Pharma Co. Limited Marketed
Protopic 0.03% ointment
EU/1/02/201/001
Tacrolimus LEO Pharma A/S โ€”
Protopic 0.03% ointment
EU/1/02/201/002
Tacrolimus LEO Pharma A/S โ€”
Protopic 0.03% ointment
EU/1/02/201/005
Tacrolimus LEO Pharma A/S โ€”
Protopic 0.1% ointment
EU/1/02/201/003
Tacrolimus LEO Pharma A/S โ€”
Protopic 0.1% ointment
EU/1/02/201/004
Tacrolimus LEO Pharma A/S โ€”
Protopic 0.1% ointment
EU/1/02/201/006
Tacrolimus LEO Pharma A/S โ€”
Protopic 0.1% Ointment
EU/1/02/202/003
Tacrolimus Astellas Pharma GmbH โ€”
Tacrolimus 0.03% ointment
PA2315/269/001
Tacrolimus Accord Healthcare Ireland Ltd. Not marketed
Tacrolimus 0.1% Ointment
PA2315/120/001
Tacrolimus Accord Healthcare Ireland Ltd. Marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.